Adverse events following COVID ‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
ConclusionAvailable literature includes more studies with the BNT162b2 vaccine than mRNA-1273. Future studies must report mortality and adverse cardiovascular events by vaccine types.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Farah Yasmin,
Hala Najeeb,
Unaiza Naeem,
Abdul Moeed,
Abdul Raafe Atif,
Muhammad Sohaib Asghar,
Nayef Nimri,
Maryam Saleem,
Dhrubajyoti Bandyopadhyay,
Chayakrit Krittanawong,
Mohammed Mahmmoud Fadelallah Eljack,
Muhammad Junaid Tahir,
Fahad Wa Tags: REVIEW ARTICLE Source Type: research
More News: Allergy & Immunology | Arrhythmia | Cardiogenic Shock | Cardiology | Cardiovascular | Clinical Trials | Coronavirus | Covid Vaccine | COVID-19 | Databases & Libraries | Electronic Medical Records (EMR) | Heart | Heart Attack | Hemorrhagic Stroke | Hypertension | Myocarditis | Pericarditis | Pfizer | Pulmonary Thromboembolism | Stroke | Study | Thrombocytopenia | Thrombosis | Vaccines